First Zantac Cancer Case to Go to Trial Ends in Win for Drugmakers

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 50%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in the first of thousands of such lawsuits to go to trial.

First Zantac Cancer Case to Go to Trial Ends in Win for DrugmakersBayer Fights for Survival as Roundup Lawsuits Burn CashNJ Governor Blasts Amtrak Over ‘Unmitigated Disaster’ in Rush Hour CommuteStarwood REIT Tightens Redemption Limits on Liquidity CrunchMusk Refuses to Say If He’s Still Committed to Cheaper Tesla EVsLarge Anglo Shareholders Are Backing Miner’s Stance on BHP TalksOil price news: Oil drifts to February lows amid physical weakness, stock slumpBird Flu Is More Widespread Among...

inflation numbers, fizzling meme stock rallyBiden Says He Kept US Troops Out of Haiti to Avoid MisperceptionSlovak Premier’s Shooter Opposed Ukraine Policy, Court Document ShowsG-7 Is Closing In on US-Led Push to Tap Frozen Russian AssetsSouth Africa Investors See Stable Coalition After ElectionBanxico Says Sticky Service Prices Call for Cautious Rate MovesMorgan Stanley and Goldman Give Up on June Rate Cut at BOEBillionaire tax rejected by U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines